Nordic Nanovector

319 articles with Nordic Nanovector

• Nordic Nanovector And Affibody Collaborate On Advanced Radio-Immunotherapies Program For Multiple Myeloma

  12/1/2014

• Nordic Nanovector And Affibody Collaborate On New Advanced Radio-Immunotherapies Program For Multiple Myeloma

  11/26/2014

• Nordic Nanovector: Extraordinary General Meeting On 12 November 2014

  11/4/2014

• Nordic Nanovector Strengthens Management Team To Prepare For Its Next Phase

  11/3/2014

• Nordic Nanovector – Registered Share Capital Increase

  10/28/2014

• Nordic Nanovector: Issuance Of Shares To HealthCap VI L.P

  10/24/2014

• Nordic Nanovector: Registered Share Capital Increase

  9/22/2014

• Nordic Nanovector: Final Result Of The Subsequent Offering

  9/16/2014

• Nordic Nanovector – Preliminary Result Of The Subsequent Offering

  9/15/2014

• Nordic Nanovector – Approved Prospectus

  8/29/2014

• Nordic Nanovector: The Board Appoints Mr. Luigi Costa As New CEO

  8/26/2014

• Nordic Nanovector: Second Quarter Report 2014

  8/26/2014

• Extraordinary General Meeting Held In Nordic Nanovector

  6/27/2014

• Nordic Nanovector Intends To Undertake Private Placement Of NOK 150 Million

  6/6/2014

• Nordic Nanovector: Betalutin™ Granted Orphan-Drug Designation In The USA

  5/20/2014

• Nordic Nanovector: Annual General Meeting Held Today

  5/14/2014

• Nordic Nanovector: Annual General Meeting held today

  5/14/2014

• Nordic Nanovector: Conversion Of MNOK 25 Convertible Loan

  5/13/2014

• Nordic Nanovector: Notice Of Annual General Meeting 2014

  5/8/2014